Through our Pharmaceutical Services & Active Ingredients (PSAI) business, which comprises the Active Pharmaceutical Ingredients (API) and Custom Pharmaceutical Services (CPS) businesses, we offer IP advantaged, speedy product development, cost-effective and robust manufacturing services to our customers, both generic companies and innovators.
Our API business seeks to make our generics customers successful, early and always. At the outset, we enable them to be the first to launch a generic product by leveraging on IP strengths. Our highly skilled API global team ensures that our customers gain the full benefits of timely product development and supply, in line with all regulatory and quality requirements.
Our CPS business serves several 'innovators', both Big Pharma and emerging biotech. Our CPS business offers both speed and flexibility. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end to end services and competitive pricing makes a compelling value proposition to our global innovator' customers.